TLR2 and tuberculosis: Thus, the site of interaction on TLR2 can dictate the downstream signaling events leading to activation of NF-κB and pro-inflammation, which can be manipulated in the regulation of inflammatory signaling during TB diseases by designing appropriate drugs to specifically block TLR2 LRR 16~20-triggered signaling cascades.